We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+5.68%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$99.9B
AUM Growth
+$8.57B
Cap. Flow
+$4.38B
Cap. Flow %
4.39%
Top 10 Hldgs %
13.65%
Holding
3,112
New
37
Increased
2,360
Reduced
269
Closed
57

Top Buys

Rank Stock Value
1
HD icon
Home Depot
HD
+$246M
2
XOM icon
ExxonMobil
XOM
+$96.1M
3
AAPL icon
Apple
AAPL
+$62M
4
VZ icon
Verizon
VZ
+$58.6M
5
BA icon
Boeing
BA
+$52.6M

Sector Composition

Rank Sector Weight
1 Technology 14.76%
2 Financials 14.54%
3 Healthcare 12.7%
4 Industrials 11.05%
5 Consumer Discretionary 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PCO
2951
DELISTED
Pendrell Corporation - Class A
PCO
$175K ﹤0.01%
269
+28
+12% +$18.3K
ASXC
2952
DELISTED
Asensus Surgical, Inc.
ASXC
$174K ﹤0.01%
11,054
GENC icon
2953
Gencor Industries
GENC
$212M
$173K ﹤0.01%
11,550
DRRX
2954
DELISTED
DURECT Corp
DRRX
$172K ﹤0.01%
16,328
-1,450
-8% -$15.5K
VANI icon
2955
Vivani Medical
VANI
$122M
$171K ﹤0.01%
5,865
+3,921
+202% +$150K
PTGX icon
2956
Protagonist Therapeutics
PTGX
$9.44B
$170K ﹤0.01%
13,200
AUTO
2957
DELISTED
AutoWeb, Inc. Common Stock
AUTO
$170K ﹤0.01%
13,500
FSTR icon
2958
Foster
FSTR
$432M
$168K ﹤0.01%
+13,435
New +$185K
NWHM
2959
DELISTED
THE NEW HOME COMPANY INC.
NWHM
$168K ﹤0.01%
16,049
TAX
2960
DELISTED
Liberty Tax, Inc. Class A
TAX
$167K ﹤0.01%
11,700
DXLG icon
2961
Destination XL Group
DXLG
$35.4M
$161K ﹤0.01%
56,400
PMBC
2962
DELISTED
Pacific Mercantile Bancorp
PMBC
$161K ﹤0.01%
21,300
NGVC icon
2963
Vitamin Cottage Natural Grocers
NGVC
$654M
$160K ﹤0.01%
15,313
+171
+1% +$2.04K
SRNE
2964
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$158K ﹤0.01%
39,855
RLH
2965
DELISTED
Red Lions Hotel Corporation
RLH
$157K ﹤0.01%
22,200
AST
2966
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$156K ﹤0.01%
45,825
NEOS
2967
DELISTED
Neos Therapeutics, Inc
NEOS
$155K ﹤0.01%
21,500
AGFS
2968
DELISTED
AgroFresh Solutions Inc
AGFS
$153K ﹤0.01%
35,000
NCIT
2969
DELISTED
NCI, Inc.
NCIT
$151K ﹤0.01%
10,000
NATR icon
2970
Nature's Sunshine
NATR
$288M
$150K ﹤0.01%
15,000
HLTH
2971
DELISTED
Nobilis Health Corp.
HLTH
$150K ﹤0.01%
88,191
SENS icon
2972
Senseonics Holdings Inc
SENS
$366M
$149K ﹤0.01%
4,157
+188
+5% +$9.08K
XONE
2973
DELISTED
The ExOne Company
XONE
$149K ﹤0.01%
14,600
TRHC
2974
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$146K ﹤0.01%
10,800
SPNE
2975
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$146K ﹤0.01%
18,517
+1,710
+10% +$12.4K

Similar funds

Charles Schwab's Q1 2017 Portfolio in Review

As of Q1 2017, Charles Schwab held 3,112 positions worth $99.9B, up 9.4% from $91.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Charles Schwab deployed $4.38B of net new capital in Q1 2017, opening 37 new positions and adding to 2,360 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 413,073 shares worth $22.5M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Chevron, an estimated $174M trimmed.

  • Charles Schwab's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 413,073 shares worth $22.5M.
  • Charles Schwab added most to Home Depot in Q1 2017, an estimated $246M increase.
  • Charles Schwab's biggest Q1 2017 reduction was Chevron, cutting an estimated $174M.
  • Charles Schwab fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $85.4M.
  • Charles Schwab's ten largest holdings make up 14% of its $99.9B portfolio in Q1 2017.
  • Charles Schwab opened 37 new positions and closed 57 in Q1 2017.
  • Charles Schwab's portfolio value rose 9.4% quarter-over-quarter to $99.9B.

Based on Charles Schwab's 13F filing for Q1 2017, filed 15 May 2017.